Need Help? Contact Us.

Enquire now

LISA-TRACKER Duo Certolizumab

Product Description

LISA-TRACKER Duo Certolizumab is an enzyme linked immunoassay for the quantitative determination of Certolizumab pegol (anti-TNFα) and anti-Certolizumab pegol antibodies in human serum samples.

  • Comprehensive menu in inflammatory diseases and oncology
  • Validated on principle drug and biosimilars
  • Ready to use reagents
  • Standardised protocols from sample collection to result interpretation
  • Automation ready – protocols available on several open platform ELISA systems
    1. Choy EHS et al. Efficacy of a novel PEGylated humanized anti-TNF (CDP870) in patients with rheumatoid arthritis: a phase II double-blinded, randomized, dose escalating trial. Rheumatology 2002;41:1133-1137.
    2. Desroches M et al. Treatment failure with antagonists of TNF-α: mechanisms and implications for the care of patients. Eur. Cytokine Netw., Vol. 21 n° 4, December 2010, 226-31.
    3. Edrees AF et al. Anti-tumor necrosis factor (TNF) therapy in rheumatoid arthritis: correlation of TNF-alpha serum level with clinical response and benefit from changing dose or frequency of infliximab infusions. Clin Exp Rheumatol. 2005 Jul-Aug;23(4):469-74.
    4. Koren E et al. Recommendation on risk-based strategies for detection and characterization of antibodies against biotechnology products. Journal of Immunological Methods, 333 (2008) 1-9.
    5. Ram Raj Singh, & al. TNFα blockade in human diseases: mechanisms and future. Clin.Immunol., 2008 February; 126(2):121-136.
    6. Vetterlein O et al. No antibodies to PEG detected in patients treated with certolizumab pegol. Ann Rheum Dis 2008;67(Suppl II):236.

Add to Enquiry Basket

LISA-TRACKER Duo Certolizumab

Quantity

Related Products

Assays Certification Platform Clinical Area Portfolio RUO/IVD
LISA-TRACKER Certolizumab CE Marked Therapeutic Drug Monitoring TDM IVD
LISA-TRACKER anti-Certolizumab CE Marked Therapeutic Drug Monitoring TDM IVD
LISA-TRACKER Duo Infliximab CE Marked Therapeutic Drug Monitoring TDM IVD
LISA-TRACKER Duo Adalimumab CE Marked Therapeutic Drug Monitoring TDM IVD
LISA-TRACKER Duo Etanercept CE Marked Therapeutic Drug Monitoring TDM IVD
LISA-TRACKER Duo Secukinumab CE Marked Therapeutic Drug Monitoring TDM IVD
LISA-TRACKER Duo Golimumab CE Marked Therapeutic Drug Monitoring TDM IVD
LISA-TRACKER Duo Ustekinumab CE Marked Therapeutic Drug Monitoring TDM IVD
This site is registered on wpml.org as a development site.